 Home > Medical News > Medicines Company News > Sirnaomics Advances GalAhead(TM) Delivery Platform-Based RNAi Therapies for Complement-Mediated-Related Diseases

Sirnaomics Advances GalAhead(TM) Delivery Platform-Based RNAi Therapies for Complement-Mediated-Related Diseases

 Last Update: 2022-09-08
 Source: Internet
 Author: User

Tags

amphetamine drug class

field control

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Sirnaomics Ltd.

Sirnaomics' proprietary GalNAc-RNAi therapy delivery platform, GalAhead™, relies on a unique RNA structure that can "silence" single or multiple mRNA targets, specifically two key technology components in its structure, mxRNA™ (miniaturized RNAi triggers) and muRNA™ (Multi-Unit RNAi Trigger)

Complement-mediated diseases are one of Sirnaomics' core therapeutic areas for products based on the GalAhead delivery platform

"We are very pleased with the performance of the company's proprietary GalAhead delivery platform, which enables us to rapidly, reproducibly and predictably expand and advance our pipeline of products based on this new technology," said Dr.

"We are encouraged by the pace of expansion of the pipeline based on the GalAhead delivery platform

Sirnaomics Ltd.

Complement-mediated diseases are one of Sirnaomics' core therapeutic areas for products based on the GalAhead delivery platform

"We are encouraged by the pace of expansion of the pipeline based on the GalAhead delivery platform

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.